Yuichiro Semba, Toshihiro Miyamoto, Senji Kasahara, Yoshikane Kikushige, Takahiro Maeda, Goichi Yoshimoto et al. Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory FLT3‐ITD–Positive AML. // Cancer Science. – 2026. – DOI: 10.1111/cas.70485. – URL: https://onlinelibrary.wiley.com/doi/10.1111/cas.70485?af=R
Yuichiro Semba, Toshihiro Miyamoto, Senji Kasahara, Yoshikane Kikushige, Takahiro Maeda, Goichi Yoshimoto, Shuichi Ota, Akio Saito, Yuho Najima, Hiroki Hosoi, Daigo Niiya, Koji Kato, Koji Nagafuji, Takashi Akasaka, Tomohiko Kamimura, Atsushi Takita, Maiko Narahara, Tadashi Toki, Koichi Iwanaga, Koji Yonemoto, Mine Harada, & Koichi Akashi (2026). Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory FLT3‐ITD–Positive AML. Cancer Science. https://doi.org/10.1111/cas.70485
Yuichiro Semba, et al. “Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory FLT3‐ITD–Positive AML.” Cancer Science, 2026. doi:10.1111/cas.70485.
@article{Semba2026,
title = {Quizartinib Resistance Mutations and Treatment Outcomes in Relapsed or Refractory FLT3‐ITD–Positive AML},
author = {Semba, Yuichiro and Miyamoto, Toshihiro and Kasahara, Senji and Kikushige, Yoshikane and Maeda, Takahiro and Yoshimoto, Goichi and Ota, Shuichi and Saito, Akio and Najima, Yuho and Hosoi, Hiroki and Niiya, Daigo and Kato, Koji and Nagafuji, Koji and Akasaka, Takashi and Kamimura, Tomohiko and Takita, Atsushi and Narahara, Maiko and Toki, Tadashi and Iwanaga, Koichi and Yonemoto, Koji and Harada, Mine and Akashi, Koichi},
journal = {Cancer Science},
year = {2026},
doi = {10.1111/cas.70485},
url = {https://onlinelibrary.wiley.com/doi/10.1111/cas.70485?af=R}
}